UC San Francisco - Articles and news items

Immunotherapy plus live bacterium shows promise in malignant pleural mesothelioma

Industry news / 14 April 2016 / Victoria White, Digital Content Producer

Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and 59% response rate in malignant pleural mesothelioma…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+